de Paiva Haddad Luciana Bertocco, Decimoni Tassia Cristina, Turri Jose Antonio, Leandro Roseli, de Soárez Patrícia Coelho
Luciana Bertocco de Paiva Haddad, Jose Antonio Turri, Department of Transplantation, Gastroenterology Division, University of São Paulo School of Medicine Hospital das Clínicas, São Paulo 05403-010, Brazil.
World J Gastrointest Pharmacol Ther. 2016 Feb 6;7(1):162-70. doi: 10.4292/wjgpt.v7.i1.162.
To systematically review economic evaluations in gastroenterology, relating to Brazil, published between 1980 and 2013.
We selected full and partial economic evaluations from among those retrieved by searching the following databases: MEDLINE (PubMed); Excerpta Medica; the Latin American and Caribbean Health Sciences Literature database; the Scientific Electronic Library Online; the database of the Centre for Reviews and Dissemination; the National Health Service (NHS) Economic Evaluation Database; the NHS Health Technology Assessment database; the Health Economics database of the Brazilian Virtual Library of Health; Scopus; Web of Science; and the Brazilian Network for the Evaluation of Health Technologies. Two researchers, working independently, selected the studies and extracted the data.
We identified 535 health economic evaluations relating to Brazil and published in the 1980-2013 period. Of those 535 articles, only 40 dealt with gastroenterology. Full and partial economic evaluations respectively accounted for 23 (57.5%) and 17 (42.5%) of the 40 studies included. Among the 23 full economic evaluations, there were 11 cost-utility analyses, seven cost-effectiveness analyses, four cost-consequence analyses, and one cost-minimization analysis. Of the 40 studies, 25 (62.5%) evaluated medications; 7 (17.5%) evaluated procedures; and 3 (7.5%) evaluated equipment. Most (55%) of the studies were related to viral hepatitis, and most (63.4%) were published after 2010. Other topics included gastrointestinal cancer, liver transplantation, digestive diseases and hernias. Over the 33-year period examined, the number of such economic evaluations relating to Brazil, especially of those evaluating medications for the treatment of hepatitis, increased considerably.
Further studies are needed in order to ensure that expenditures on health care in Brazil are made as fairly and efficiently as possible.
系统回顾1980年至2013年间发表的与巴西相关的胃肠病学领域的经济学评价。
我们从以下数据库检索到的文献中筛选出完整和部分经济学评价：医学索引数据库（PubMed）；医学文摘；拉丁美洲和加勒比卫生科学文献数据库；科学电子图书馆在线；循证医学中心数据库；英国国家医疗服务体系（NHS）经济学评价数据库；NHS卫生技术评估数据库；巴西虚拟健康图书馆卫生经济学数据库；Scopus；科学引文索引；以及巴西卫生技术评估网络。两名研究人员独立筛选研究并提取数据。
我们识别出1980 - 2013年间发表的535项与巴西相关的卫生经济学评价。在这535篇文章中，仅40篇涉及胃肠病学。完整和部分经济学评价分别占纳入的40项研究中的23项（57.5%）和17项（42.5%）。在23项完整经济学评价中，有11项成本效用分析、7项成本效果分析、4项成本后果分析和1项成本最小化分析。在40项研究中，25项（62.5%）评估药物；7项（17.5%）评估诊疗程序；3项（7.5%）评估设备。大多数（55%）研究与病毒性肝炎相关，且大多数（63.4%）发表于2010年之后。其他主题包括胃肠道癌症、肝移植、消化系统疾病和疝气。在考察的33年期间，与巴西相关的此类经济学评价数量大幅增加，尤其是评估治疗肝炎药物的评价。
需要进一步开展研究，以确保巴西的医疗保健支出尽可能公平且高效。
